C. Norman Coleman
Investigator
Radiation Oncology Branch, Radiation Research Program, DCTD
National Cancer Institute
United States of America
Biography
Dr. Coleman graduated from the University of Vermont with a B.A. in mathematics, and then graduated from Yale University School of Medicine in 1970. He completed his internship and residency in internal medicine at the University of California in San Francisco, medical oncology at the NCI and radiation oncology at Stanford. Board certified in internal medicine, medical oncology and radiation oncology, Dr. Coleman was a tenured faculty member at the Stanford University School of Medicine before joining Harvard Medical School in 1985 as Fuller-American Cancer Society Professor and Chairman, Joint Center for Radiation Therapy. In 1999, he came to the NCI and became director of the new Radiation Oncology Sciences Program that he created to coordinate all radiation oncology activities. He served as chief of the Radiation Oncology Branch from 1999- 2004 and is now an adjunct member of ROB. He serves the NCI as associate director of the Radiation Research Program (in DCTD). Since 2004 he has been Senior Medical Advisor and medical chief of the CBRNE Team in the Office of Assistant Secretary for Preparedness and Response (ASPR), DHHS. He has written extensively in the fields of radiation modifiers and, more recently, on preparedness and planning for radiological or nuclear emergencies and also global health. In addition to fellowships in a number of medical societies, he received the ASTRO Gold Medal in 2005, the Service to America Homeland Security Medal in 2011, the Failla Medal from the Radiation Research Society in 2016 and a Doctor of Science (h.c) from the University of Vermont in 2015.
Research Interest
1) Radiation oncology 2) Radiation biology 3) Molecular targeted therapy 4) Radiation stress response for tumor and normal tissue 5) Global health 6) Health disparities 7) long-standing interest in the tumor-induced and radiation-induced stress responses 8) development of biomarkers 9) Cancer Biology, 10) Genetics and Genomics, 11) Immunology, 12) Molecular Biology and Biochemistry.
Publications
-
Stone HB, Bernhard EJ, Coleman CN, Deye J, Capala J, Mitchell JB, Brown JM. Preclinical data on efficacy of 10 drug-radiation combinations: evaluations, concerns, and recommendations. Translational oncology. 2016 Feb 29;9(1):46-56.
-
FitzGerald TJ, Bishop-Jodoin M, Followill DS, Galvin J, Knopp MV, Michalski JM, Rosen MA, Bradley JD, Shankar LK, Laurie F, Cicchetti MG. Imaging and data acquisition in clinical trials for radiation therapy. International Journal of Radiation Oncology* Biology* Physics. 2016 Feb 1;94(2):404-11.
-
Coleman CN, Higgins GS, Brown JM, Baumann M, Kirsch DG, Willers H, Prasanna PG, Dewhirst MW, Bernhard EJ, Ahmed MM. Improving the predictive value of preclinical studies in support of radiotherapy clinical trials. Clinical Cancer Research. 2016 Jul 1;22(13):3138-47.